Cargando…

Perspectives for repurposing drugs for the coronavirus disease 2019

The newly emerged 2019 novel coronavirus (CoV), named as severe acute respiratory syndrome CoV-2 (SARS-CoV-2), like SARS-CoV (now, SARS-CoV-1) and Middle East respiratory syndrome CoV (MERS-CoV), has been associated with high infection rates with over 36,405 deaths. In the absence of approved market...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cherian, Sarah S., Agrawal, Megha, Basu, Atanu, Abraham, Priya, Gangakhedkar, Raman R., Bhargava, Balram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357399/ https://www.ncbi.nlm.nih.gov/pubmed/32317408 http://dx.doi.org/10.4103/ijmr.IJMR_585_20

Ejemplares similares

Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020
por: Gupta, Nivedita, et al.
Publicado: (2020)

Drug repurposing against coronavirus disease 2019 (COVID-19): A review
por: Luo, Lianxiang, et al.
Publicado: (2021)

Topological network based drug repurposing for coronavirus 2019
por: Habibi, Mahnaz, et al.
Publicado: (2021)

Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
por: Fan, Hua-Hao, et al.
Publicado: (2020)

Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?
por: Vassileva, Snejina, et al.
Publicado: (2021)

Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
por: Bhise, Neha, et al.
Publicado: (2023)

The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence
por: Chatterjee, Pranab, et al.
Publicado: (2020)

Artificial intelligence methods to repurpose and discover new drugs to fight the Coronavirus disease-2019 pandemic
por: Santana, Marcos V.S., et al.
Publicado: (2022)

Transmission electron microscopy imaging of SARS-CoV-2
por: Prasad, Sharda, et al.
Publicado: (2020)

A Panel of Broad-Spectrum Antivirals in Topical Ophthalmic Medications from the Drug Repurposing Approach during and after the Coronavirus Disease 2019 Era
por: Napoli, Pietro Emanuele, et al.
Publicado: (2020)

The burgeoning cardiovascular disease epidemic in Indians – perspectives on contextual factors and potential solutions
por: Kalra, Ankur, et al.
Publicado: (2023)

Perspectives of Immune Therapy in Coronavirus Disease 2019
por: Gasparyan, Armen Yuri, et al.
Publicado: (2020)

Repurposing old drugs as antiviral agents for coronaviruses
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Strategies for drug repurposing against coronavirus targets
por: Smith, Poppy O., et al.
Publicado: (2021)

A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing
por: Kumar, S. Udhaya, et al.
Publicado: (2021)

Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
por: Al-Karmalawy, Ahmed A., et al.
Publicado: (2021)

Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
por: Campbell, Courtney M., et al.
Publicado: (2020)

Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
por: Lisi, Lucia, et al.
Publicado: (2020)

Full-genome sequences of the first two SARS-CoV-2 viruses from India
por: Yadav, Pragya D., et al.
Publicado: (2020)

Perspective: repurposed drugs for COVID-19
por: Na-Bangchang, Kesara, et al.
Publicado: (2022)

Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use
por: Bhatnagar, Tarun, et al.
Publicado: (2020)

Letter to the Editor: Coronavirus Disease 2019 and Resilience: Neurosurgical Perspectives
por: Rahman, Moshiur, et al.
Publicado: (2020)

Powerless in the ICU: Perspectives from ICUs in the Face of Coronavirus Disease 2019
por: Ramachandran, Pradeep, et al.
Publicado: (2020)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach
por: Mandal, Sandip, et al.
Publicado: (2020)

Coronavirus Disease 2019: A Gastroenterologist’s Perspective in May 2020
por: Ahmed, Monjur
Publicado: (2020)

Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019)
por: Farooq, Saba, et al.
Publicado: (2020)

Review of investigational drugs for coronavirus disease 2019
por: Sharma, Dhruva, et al.
Publicado: (2021)

Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
por: Geisler, Benjamin P., et al.
Publicado: (2020)

Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review
por: Geisler, Benjamin P., et al.
Publicado: (2021)

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
por: Zhou, Yadi, et al.
Publicado: (2020)

Pediatric Dentistry during Coronavirus Disease-2019 Pandemic: A Paradigm Shift in Treatment Options
por: Sharma, Amita, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19): A Pediatric Perspective
por: Shrestha, Rupesh, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Human Reproduction: A Changing Perspective
por: Delamuta, Luciana C., et al.
Publicado: (2021)

Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India
por: Choudhary, Manohar Lal, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Diabetes: The Epidemic and the Korean Diabetes Association Perspective
por: Noh, Junghyun, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19): A Perspective from China
por: Zu, Zi Yue, et al.
Publicado: (2020)

Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers
por: Meco, Daniela, et al.
Publicado: (2023)

Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March–May 2020
por: Kadri, Sameer S, et al.
Publicado: (2020)

Intracardiac Thrombus in Coronavirus Disease-2019
por: Karikalan, Suganya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_73qd8nj7m3jm1gs7q0r9bv0mdq